drugset / Trial / NCT06833411
Treatment for Giant Cell Arteritis With Tocilizumab and 8 as Compared to 26 Weeks of Prednisone
RandomizedSingle-groupQuadruple-blindTreatment
Summary
The GISCO study plans to determine whether 8-week therapy is just as effective as 26-week cortisone therapy for treating giant cell arteritis * with tocilizumab, * while using less cortisone.
Timeline
- Start
- 2026-07
- Primary completion
- 2030-08
- Completion
- 2032-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Prednisone | Other / unclassified | — | — |